GRCE READ THE FULL GRCE RESEARCH REPORT Grace Therapeutics, Inc (NASDAQ:GRCE) will soon submit its new drug application (NDA) ...

The Nigerian Defence Academy (NDA) in Kaduna state, on Tuesday, June 3, 2025, announced the new date for the 77 Regular ...

The last Census of India was conducted in 2011 in two phases. What is new in this exercise is that the enumeration of caste ...

Often tagged as BJP's 'B team' by the RJD and Congress, Asaduddin Owaisi's AIMIM has expressed interest to join the ...

A law that would prevent the use of non-disclosure agreements (NDAs) in civil settlements for sexual abuse victims is now ...

If approved, ziftomenib could be the first FDA-approved Menin inhibitor for relapsed/refractory acute myeloid leukemia with ...

U.S. adults per year claim reimbursement for medical costs associated with babesiosis v. CDC estimates of 2,000 <li /> A full 45 ...

XENOVIEW™, prepared from the Xenon Xe 129 Gas Blend, is a hyperpolarized contrast agent indicated for use with magnetic resonance imaging (MRI) for evaluation of lung ventilation in adults and ...

Robust broad-spectrum efficacy sustained over 1-year across all symptom domains including negative symptoms - - Generally ...

Know the full form of UPSC CSE and understand its meaning, purpose, exam stages, and eligibility. Start your journey towards ...

(RTTNews) - Kura Oncology Inc. (KURA) and Kyowa Kirin Co., Ltd. announced the U.S. Food and Drug Administration has accepted Kuras New Drug Application or NDA seeking full approval for ziftomenib as a ...